OvaVision is transforming the fertility industry with AI-driven solutions. With a PhD in Biophysics from Harvard University, Helen’s interdisciplinary research spans clinical IVF, physics, biology, and computer science. Her diverse expertise drives innovative approaches to reproductive health, integrating cutting-edge technology with deep scientific knowledge.

​

OvaVision’s BlastAssist platform leverages interpretable artificial intelligence to analyze cellular-level data, helping clinicians select the most viable embryos. This approach increases IVF success rates and improves patient outcomes. Supported by a team of leading scientists in fertility and AI, OvaVision is paving the way for more accurate, affordable, and effective fertility treatments.